Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.
ErbB-2 and EGFR (epidermal growth factor receptor) are expressed in lung adenocarcinomas and associated with a poor prognosis. Immunocytochemical analysis revealed erbB-2 and EGFR coexperession as a characteristic feature of most lung adenocarcinomas, and at levels of receptor expression present in...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
1995
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034126/ |